Product Information
OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1496 per ML under NDC 68180067801. Its NADAC has been published 447 times since Mar 14, 2018.
FDA first approved this application on Feb 20, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180067801
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA208347FDA Approved
2/20/2018
TE Code
AB
On Market Since
2/21/2018
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 447 times since Mar 14, 2018, and over the history we have for it it has declined 90.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1496 per ML |
|---|---|
| All-time high | $1.5268 (Apr 11, 2018) |
| All-time low | $0.1271 (Nov 20, 2024) |
| 52-week high | $0.1739 |
| 52-week low | $0.1496 |
| Median price | $0.3892 |
| Average price | $0.5284 |
| Largest weekly change | -56.9% (Sep 20, 2023) |
| Weeks tracked | 447 |
| Tracking since | Mar 14, 2018 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oseltamivir Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Neuraminidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Lupin Pharmaceuticals Inc., is $0.1496 per ML (NDC 68180067801), effective Sep 30, 2026.
How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 90.2%. It has been tracked across 447 weekly CMS publications since Mar 14, 2018.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?
Since Mar 14, 2018, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $1.5268 (Apr 11, 2018), with a median of $0.3892 per ML.
Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.
Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?
OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 68180067801) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.